S tocks of anti-obesity drugmakers Eli Lilly , Novo Nordisk , and Amgen have gotten hit as the market frets over what a Robert F. Kennedy Jr.-run Department of Health and Human Se ...

Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BMO Capital analyst Evan Seigerman has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

While Rory McIlroy’s wait for a fifth major title went on after his near US Open miss, the Northern Irish star still enjoyed ...

Lowering BMI alone may reduce the risk of various obesity-related diseases, but other factors might also play a role. A new ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Some industry leaders are confident health care products such as drugs will be carved out of expected Trump administration tariffs ...

Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.

Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...